Efficient production of complement (C3d)3 fusion proteins using the baculovirus expression vector system

被引:8
作者
Barrault, DV
Steward, M
Cox, VF
Smith, RAG
Knight, AM
机构
[1] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland
[2] Lab901 Ltd, Bilston Glen Ind Estate, IMEX Business Ctr, Loanhead EH20 9LZ, Midlothian, Scotland
[3] Domantis Ltd, Cambridge CB4 0WG, England
[4] Springwell Ltd, London Biosci Innovat Ctr, London NW1 0NH, England
[5] Inflazyme Pharmaceut Ltd, Richmond, BC V6V 2M2, Canada
基金
英国惠康基金;
关键词
adjuvant; B cells; complement; immunogenicity; protein expression; tetanus toxin;
D O I
10.1016/j.jim.2005.07.013
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Proteins fused to activated complement (C) fragments elicit enhanced immunogenicity. This "natural adjuvant effect may have important implications when considering novel vaccination approaches. Here we describe both the construction of a novel fusion protein, consisting of a well characterized test antigen fused to multiple copies of the activated complement component (C3d)(3), as well as an efficient method for its expression and production in insect cells. Using the inherent biological advantages of the baculovirus expression system, as well as applying specific infection and harvesting modifications, we have optimized the efficiency of protein production. Our modifications allow purification of fusion proteins directly from cell supernatant in a single anion exchange chromatographic step. This alleviates the requirement for the inclusion of protein affinity tags. The integrity of the purified recombinant protein was evaluated by SDS PAGE analysis, reactivity with antibodies, as well as in vivo by administration as an immunogen. (c) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:158 / 173
页数:16
相关论文
共 31 条
[1]   Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen [J].
Ahearn, JM ;
Fischer, MB ;
Croix, D ;
Goerg, S ;
Ma, MH ;
Xia, JR ;
Zhou, XN ;
Howard, RG ;
Rothstein, TL ;
Carroll, MC .
IMMUNITY, 1996, 4 (03) :251-262
[2]  
Antoniou AN, 2002, EUR J IMMUNOL, V32, P530, DOI 10.1002/1521-4141(200202)32:2<530::AID-IMMU530>3.0.CO
[3]  
2-X
[4]   Distinct sequences in the cytoplasmic domain of complement receptor 2 are involved in antigen internalization and presentation [J].
Barrault, DV ;
Knight, AM .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3509-3517
[5]   B lymphocyte memory:: Role of stromal cell complement and FcγRIIB receptors [J].
Barrington, RA ;
Pozdnyakova, O ;
Zafari, MR ;
Benjamin, CD ;
Carroll, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (09) :1189-1199
[6]   CD21 augments antigen presentation in immune individuals [J].
Boackle, SA ;
Holers, VM ;
Karp, DR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (01) :122-129
[7]  
CARTER RH, 1988, J IMMUNOL, V141, P457
[8]   The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens [J].
Cherukuri, A ;
Cheng, PC ;
Pierce, SK .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :163-172
[9]  
Cherukuri A, 2001, IMMUNITY, V14, P169
[10]   C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity [J].
Dempsey, PW ;
Allison, MED ;
Akkaraju, S ;
Goodnow, CC ;
Fearon, DT .
SCIENCE, 1996, 271 (5247) :348-350